肺癌治疗中EGFR-TKI 耐药与PD-L1 表达的关系.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 171, doi. 10.3872/j.issn.1007-385x.2021.02.011
- By:
- Publication type:
- Article
Works matching IS 1007385X AND DT 2021 AND VI 28 AND IP 2
Results: 15
1
2
不同细胞来源外泌体对肿瘤微环境的重塑作用.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 191, doi. 10.3872/j.issn.1007-385x.2021.02.014
- By:
- Publication type:
- Article
3
肿瘤靶向穿透肽修饰在肿瘤腹膜转移中的应用.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 184, doi. 10.3872/j.issn.1007-385x.2021.02.013
- By:
- Publication type:
- Article
4
含笑内酯通过促进自噬增强结直肠癌细胞对奥沙利铂的敏感性.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 115, doi. 10.3872/j.issn.1007-385x.2021.02.003
- By:
- Publication type:
- Article
5
PDGF-BB 通过外泌体促进人骨肉瘤的血管新生.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 128, doi. 10.3872/j.issn.1007-385x.2021.02.005
- By:
- Publication type:
- Article
6
食管鳞状细胞癌研究模型：细胞系、动物移植模型和3D 培养模型.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 199, doi. 10.3872/j.issn.1007-385x.2021.02.015
- By:
- Publication type:
- Article
7
抗生素对免疫检查点抑制剂治疗非小细胞肺癌疗效影响的 Meta 分析.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 165, doi. 10.3872/j.issn.1007-385x.2021.02.010
- By:
- Publication type:
- Article
8
过表达血管生成抑制蛋白1 对人结直肠癌细胞恶性生物学行为的影响.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 121, doi. 10.3872/j.issn.1007-385x.2021.02.004
- By:
- Publication type:
- Article
9
间充质干细胞作为溶瘤病毒细胞载体的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 176, doi. 10.3872/j.issn.1007-385x.2021.02.012
- By:
- Publication type:
- Article
10
综合性分析miR-224 在肝癌中的表达及其生物学作用.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 135, doi. 10.3872/j.issn.1007-385x.2021.02.006
- By:
- Publication type:
- Article
11
维生素E 琥珀酸酯诱导内质网应激激活JNK 的表达对人胃癌SGC-7901 细胞自噬的影响
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 109, doi. 10.3872/j.issn.1007-385x.2021.02.002
- By:
- Publication type:
- Article
12
黑色素瘤患者种系抗原及核抗原Ki-67 的表达水平及其与预后的关系.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 157, doi. 10.3872/j.issn.1007-385x.2021.02.009
- By:
- Publication type:
- Article
13
可溶性PD-L1 作为晚期肢端及黏膜黑色素瘤预后因素的研究.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 151, doi. 10.3872/j.issn.1007-385x.2021.02.008
- By:
- Publication type:
- Article
14
miR-449b-5p 通过靶向Cyclin E2 抑制卵巢癌细胞生长和细胞周期进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 143, doi. 10.3872/j.issn.1007-385x.2021.02.007
- By:
- Publication type:
- Article
15
T 淋巴细胞归巢：实体肿瘤过继性细胞治疗的关键因素.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 2, p. 103, doi. 10.3872/j.issn.1007-385x.2021.02.001
- By:
- Publication type:
- Article